Medicine

The new U.S. plan to target xylazine-laced fentanyl

Researchers from Penn LDI, in conjunction with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, analyze the plan and raise the question of whether it goes far enough.

From Penn LDI



Media Contact


In the News


Philadelphia Inquirer

My brother’s recovery from a car crash became a lesson in how to talk to doctors and nurses

Emily Largent of the Perelman School of Medicine writes that communication is part of healing, as she experienced when her brother was in a car accident and unable to notify family himself.

FULL STORY →



Philadelphia Inquirer

In-hospital strokes like Charlie Manuel’s are common

Steven Messé of the Perelman School of Medicine has been working on a solution to a long-standing problem in stroke care and says that for a variety of reasons in-hospital strokes sometimes are not detected until hours after they occur.

FULL STORY →



Philadelphia Business Journal

Penn researcher’s Every Cure nonprofit lands ‘game-changing’ support as it works to help patients with uncurable diseases

David Fajgenbaum of the Perelman School of Medicine comments on “game-changer” funding for the nonprofit Every Cure, which he co-founded.

FULL STORY →



Philadelphia Inquirer

Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space

More than 50 Penn scientists and staff, including the Perelman School of Medicine’s Drew Weissman, are moving into 115,000 square feet of new lab space in the 13-story One uCity Square building.

FULL STORY →



Philadelphia Inquirer

The White House proposed staffing requirements for nursing home. What would that mean for Pennsylvania?

Rachel Werner of the Leonard Davis Institute, the Perelman School of Medicine, and the Wharton School explains why an increase in nursing home staffing levels is sorely needed.

FULL STORY →



The Washington Post

Silicon Valley’s quest to live forever now includes $2,500 full-body MRIs

Saurabh Jha of the Perelman School of Medicine says that the only way to know if incidental MRI findings are benign is to keep getting scanned, which is costly to the individual and to the health system.

FULL STORY →